Literature DB >> 16374327

Saving cone cells in hereditary rod diseases: a possible role for rod-derived cone viability factor (RdCVF) therapy.

José-Alain Sahel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16374327     DOI： 10.1097/00006982-200512001-00015

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  11 in total

1.  Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

Authors:  J Pang; S E Boye; B Lei; S L Boye; D Everhart; R Ryals; Y Umino; B Rohrer; J Alexander; J Li; X Dai; Q Li; B Chang; R Barlow; W W Hauswirth
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

2.  Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse.

Authors:  Bärbel Rohrer; Christina Demos; Rico Frigg; Christian Grimm
Journal:  Exp Eye Res       Date:  2006-10-25       Impact factor: 3.467

3.  Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration.

Authors:  Matthew M LaVail; Shimpei Nishikawa; Roy H Steinberg; Muna I Naash; Jacque L Duncan; Nikolaus Trautmann; Michael T Matthes; Douglas Yasumura; Cathy Lau-Villacorta; Jeannie Chen; Ward M Peterson; Haidong Yang; John G Flannery
Journal:  Exp Eye Res       Date:  2017-11-06       Impact factor: 3.467

4.  The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina.

Authors:  Ram Fridlich; Francois Delalande; Céline Jaillard; Jun Lu; Laetitia Poidevin; Thérèse Cronin; Ludivine Perrocheau; Géraldine Millet-Puel; Marie-Laure Niepon; Olivier Poch; Arne Holmgren; Alain Van Dorsselaer; Jose-Alain Sahel; Thierry Léveillard
Journal:  Mol Cell Proteomics       Date:  2009-03-11       Impact factor: 5.911

5.  Halting progressive neurodegeneration in advanced retinitis pigmentosa.

Authors:  Susanne F Koch; Yi-Ting Tsai; Jimmy K Duong; Wen-Hsuan Wu; Chun-Wei Hsu; Wei-Pu Wu; Luis Bonet-Ponce; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  J Clin Invest       Date:  2015-08-24       Impact factor: 14.808

6.  Functional rescue of degenerating photoreceptors in mice homozygous for a hypomorphic cGMP phosphodiesterase 6 b allele (Pde6bH620Q).

Authors:  Richard J Davis; Joaquin Tosi; Kerstin M Janisch; J Mie Kasanuki; Nan-Kai Wang; Jian Kong; Ilene Tsui; Marianne Cilluffo; Michael L Woodruff; Gordon L Fain; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-24       Impact factor: 4.799

7.  Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential.

Authors:  Frédéric Chalmel; Thierry Léveillard; Céline Jaillard; Aurélie Lardenois; Naomi Berdugo; Emmanuelle Morel; Patrice Koehl; George Lambrou; Arne Holmgren; José A Sahel; Olivier Poch
Journal:  BMC Mol Biol       Date:  2007-08-31       Impact factor: 2.946

8.  p38 MAPK signaling acts upstream of LIF-dependent neuroprotection during photoreceptor degeneration.

Authors:  C Agca; A Gubler; G Traber; C Beck; C Imsand; D Ail; C Caprara; C Grimm
Journal:  Cell Death Dis       Date:  2013-09-05       Impact factor: 8.469

9.  Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.

Authors:  Jung-A Shin; Hwa Sun Kim; Andrew Vargas; Wan-Qing Yu; Yun Sung Eom; Cheryl Mae Craft; Eun-Jin Lee
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 10.  Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases.

Authors:  Mohammad Amir Mishan; Mozhgan Rezaei Kanavi; Koorosh Shahpasand; Hamid Ahmadieh
Journal:  J Ophthalmic Vis Res       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.